NUZ 2.17% 22.5¢ neurizon therapeutics limited

Ann: PharmAust Expands Lymphoma Canine Trial to the USA, page-54

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,068 Posts.
    lightbulb Created with Sketch. 2169
    Hi All,

    @TheBrownHornet post 12/05 1113 hrs , you are correct.
    @beazle , the future expenditure is very much within parameters.
    @Peeteepoo 13/05 1202hrs , your first two paragraphs are correct.
    @Lastly get well.
    @adreamer enjoy your holiday from we annoying "school kids"

    At one stage we had a synergy with Vet Major, if you research some old RA videos , you will see that we had problems obtaining the full safety data.

    Soon we will be totally and I underline independent.

    In relation to the last announcement.
    This is the first time, Pharmaust has penetrated the USA with MPL. What a great step forward.

    I initially bought in to this Company for the canine cancer. In this regard I can see the light at the end of the tunnel.




 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.